The 9th Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy, held at the Old Great Hall, College of Medicine, University of Lagos, served as a rallying point for experts to address the escalating crisis of antimicrobial resistance (AMR). As Nigeria prepares to host the Fifth Global High-Level Ministerial Conference on Antimicrobial Resistance in Abuja this December, the discourse highlighted the critical intersection of clinical practice, policy enforcement, and scientific innovation in preserving the efficacy of life-saving medications.
The Rising Tide of Antimicrobial Resistance
Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve to withstand the drugs specifically designed to eliminate them. This phenomenon has transitioned from a clinical concern to a global public health emergency. Keynote speaker and Consultant Community Pharmacist, Pharm. Folasade Olufunke Lawal, presented a sobering analysis of the data, noting that 2021 global estimates attributed 1.14 million deaths directly to bacterial AMR, with an additional 4.71 million deaths associated with resistant infections.
In the Nigerian context, the statistics are particularly alarming. Approximately 50,500 deaths were directly caused by AMR in 2021, while 227,000 deaths were linked to the condition. Vulnerable populations, specifically children under the age of five, carry the highest burden of this mortality. Beyond the immediate loss of life, the economic implications are severe. Projections suggest that by 2050, Nigeria could face a decline of 5% to 7% in its Gross Domestic Product, while the agricultural sector—a backbone of the nation’s food security—could see livestock production plummet by 11% due to the inability to effectively treat animal infections.
Drivers of Resistance: A Complex Ecosystem
The proliferation of resistant strains in Nigeria is not the result of a single factor but rather a synergy of systemic failures. Pharm. Lawal identified several primary drivers:

- Indiscriminate Use: The widespread practice of self-medication and the acquisition of antibiotics without professional medical oversight.
- Regulatory Gaps: Weak enforcement of existing laws governing the dispensing of prescription-only medicines.
- Supply Chain Integrity: The infiltration of substandard and falsified antimicrobial products into the market.
- Agricultural Misuse: The indiscriminate application of antibiotics in the poultry, cattle, and aquaculture sectors for growth promotion rather than therapeutic necessity.
- Diagnostic Deficiencies: A lack of robust, accessible laboratory facilities that allow clinicians to identify the specific pathogen, leading to the common practice of empiric, broad-spectrum antibiotic prescribing.
Stewardship as a Clinical Imperative
The lecture distinguished clearly between the state of resistance and the practice of stewardship. Antimicrobial stewardship is defined as the coordinated, multidisciplinary effort to ensure that antimicrobials are used only when absolutely necessary, and when used, are delivered in the correct drug, dose, route, and duration.
Pharm. Lawal emphasized that stewardship is a daily responsibility for the pharmacist, particularly at the community pharmacy level, which often acts as the first point of care for the public. "Every time one of us says, ‘No, you don’t need this antibiotic,’ and explains why, that is stewardship," she noted. This requires a shift in the pharmacist’s role from a mere vendor of medicine to a frontline clinical gatekeeper who performs medication reviews, monitors prescription adherence, and provides public health education.
Chronology and Policy Context
The discourse at the University of Lagos did not occur in a vacuum. Nigeria has made documented attempts to legislate and regulate the use of antimicrobials over the last decade:
- 2017: The Federal Government launched the first National Action Plan on Antimicrobial Resistance, signaling a commitment to a "One Health" approach—a collaborative strategy recognizing that human health is inextricably linked to animal health and environmental sustainability.
- 2024–2028: The introduction of the second One Health National Action Plan. Despite these policy frameworks, the consensus among experts at the lecture was that implementation remains fragmented, with stewardship committees largely confined to high-end tertiary healthcare institutions, leaving the primary and community healthcare sectors underserved.
Institutional Responses and Strategic Calls to Action
Representing the Vice-Chancellor of the University of Lagos, Prof. Folasade Ogunsola, Prof. Niyi Oshuntoki underscored the necessity of a unified front. "Microorganisms naturally develop survival mechanisms, but our inappropriate activities are accelerating this process," he stated. He urged for a holistic approach where pharmacists, doctors, nurses, and veterinarians collaborate to move beyond silos.
Professor Oluwole Familoni, Chairman of the Board of Trustees for the lecture series, advocated for a transition from policy-on-paper to systemic change. He proposed that Nigeria must prioritize:

- Strengthened Enforcement: Empowering regulatory bodies to act against the illegal sale of antibiotics.
- Diagnostic Infrastructure: Increasing investment in laboratory services to ensure that treatment is based on evidence rather than assumption.
- Surveillance Systems: Establishing real-time tracking of antimicrobial consumption and resistance patterns across the country.
Former President of the Pharmaceutical Society of Nigeria, Pharm. Olumide Akintayo, provided a dire warning regarding the future. Citing World Health Organization projections, he noted that the world faces the potential of nearly 40 million deaths related to AMR between 2025 and 2050. He challenged the profession to evolve its strategies to ensure that the healthcare value chain ceases to be a catalyst for resistance.
Advancing Research: The Ladipo Mobolaji Abisogun-Afodu Grant
A significant highlight of the event was the awarding of the N2.7 million research grant to Dr. Olusegun Ajala of the Department of Pharmaceutical Chemistry at the University of Lagos. His winning proposal, "Development of a Psidium guajava-Based Antibiotic Adjuvant for Restoring the Susceptibility of Multidrug-Resistant Bacteria to Conventional Antibiotics," represents a cutting-edge approach to the crisis. By utilizing natural extracts to potentially re-sensitize resistant bacteria to existing antibiotics, the research aims to extend the lifespan of drugs that are currently losing their effectiveness.
The selection process was rigorous, with seven applications submitted and three shortlisted. The runners-up also presented innovative, practical solutions:
- Deborah Ogundemuren (Department of Pharmaceutics and Pharmaceutical Technology): Proposed the development of a bioactive, sprayable hydrogel for postpartum perineal wound care, aimed at reducing the systemic need for antibiotics in post-surgical or obstetric recovery.
- Osideko Oluwaseun (Department of Pharmaceutical Chemistry): Focused on the chemical standardization and antibacterial characterization of omidun (fermented maize mash supernatant), exploring traditional fermented products as potential antimicrobial agents.
Broader Implications and Future Outlook
The 9th Ladipo Mobolaji Abisogun-Afodu Annual Lecture served as both a memorial to a legacy of pharmaceutical excellence and a call to arms for a new generation of scientists and practitioners. The Dean of the Faculty of Pharmacy, Prof. Sunday Adesegun, reinforced the faculty’s commitment to integrating antimicrobial stewardship into the pharmacy curriculum, ensuring that graduates are equipped not just with technical knowledge, but with the leadership skills required to influence public health outcomes.
The consensus reached by the assembly is clear: antibiotics are a finite, precious resource. If the current trajectory of indiscriminate use and regulatory laxity continues, the medical community risks entering a "post-antibiotic era" where common infections and minor surgeries could once again become life-threatening. The responsibility, as outlined by the keynote speakers and trustees, rests on a collective transformation of behavior—from the prescriber’s pen to the patient’s compliance, and from the laboratory bench to the policy maker’s desk. As the nation prepares to host the global ministerial conference in December, the outcomes of this lecture provide a roadmap for Nigeria to emerge as a leader in the global fight against antimicrobial resistance.


